saclofen has been researched along with formaldehyde in 2 studies
| Studies (saclofen) | Trials (saclofen) | Recent Studies (post-2010) (saclofen) | Studies (formaldehyde) | Trials (formaldehyde) | Recent Studies (post-2010) (formaldehyde) |
|---|---|---|---|---|---|
| 107 | 0 | 20 | 22,546 | 243 | 5,887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khodayar, MJ; Naderi, N; Shafaghi, B; Zarindast, MR | 1 |
| Akada, Y; Kato, Y; Mochizuki, H; Mori, R; Yamasaki, F | 1 |
2 other study(ies) available for saclofen and formaldehyde
| Article | Year |
|---|---|
Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.
Topics: Analysis of Variance; Animals; Baclofen; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Formaldehyde; GABA Agonists; GABA Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Injections, Spinal; Male; Pain; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Rimonabant; Signal Transduction; Spinal Cord | 2005 |
Analgesic properties of the novel compound M43068 in rat models of acute and neuropathic pain.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Baclofen; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Formaldehyde; GABA Antagonists; GABA-B Receptor Antagonists; Hyperalgesia; Male; Neural Inhibition; Nociceptors; Pain; Pain Threshold; Prazosin; Propionates; Rats; Rats, Wistar; Sciatic Nerve; Sciatic Neuropathy; Sympathetic Nervous System; Time Factors; Touch | 2005 |